Finance

Lists
300584:SHE
Nanjing Hicin Pharmaceutical Co Ltd
CNÂ¥31.30
+1.13%
(+0.35) 1D
Sep 8, 3:04:43 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300584...
Open
CNÂ¥31.24
High
CNÂ¥31.30
Low
CNÂ¥30.60
Mkt. cap
3.67B
Avg. vol.
4.26M
Volume
1.78M
Dividend
0.32%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 25, 2026
P/E ratio
84.62
52-wk high
CNÂ¥81.88
52-wk low
CNÂ¥27.68
EPS
CNÂ¥0.37
Shares outstanding
120.00M
No. of employees
553
Open
CNÂ¥31.24
High
CNÂ¥31.30
Low
CNÂ¥30.60
Mkt. cap
3.67B
Avg. vol.
4.26M
Volume
1.78M
Dividend
0.32%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 25, 2026
P/E ratio
84.62
52-wk high
CNÂ¥81.88
52-wk low
CNÂ¥27.68
EPS
CNÂ¥0.37
Shares outstanding
120.00M
No. of employees
553
About Nanjing Hicin Pharmaceutical Co Ltd
CEO-
Employees553
FoundedJan 15, 2003
Headquarters-
SectorPharmaceutical industry
Websitehicin.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
162.95M
199.52M
160.34M
203.81M
Cost of goods sold
25.46M
45.82M
34.56M
63.83M
Cost of revenue
25.46M
45.82M
34.56M
63.83M
Research and development expenses
14.30M
9.25M
4.51M
5.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102.58M
109.20M
98.16M
95.67M
Operating expense
119.51M
125.33M
105.61M
104.50M
Total operating expenses
144.98M
171.15M
140.17M
168.33M
Operating income
17.98M
28.37M
20.17M
35.48M
Other non operating income
34.15K
-33.85K
-240.85K
-9.12M
EBT including unusual items
3.52M
12.45M
14.98M
23.02M
EBT excluding unusual items
16.60M
26.63M
18.49M
26.17M
Income tax expense
203.45K
3.91M
-1.35M
6.46M
Effective tax rate
5.78%
31.43%
-9.01%
28.05%
Other operating expenses
3.33M
5.07M
3.42M
2.97M
Net income
3.52M
9.38M
17.36M
14.70M
Net profit margin
2.16%
4.70%
10.83%
7.21%
Earnings per share
-
-
-
-
Interest and investment income
12.03K
9.56K
10.29K
1.45M
Interest expense
-1.40M
-1.73M
-1.45M
-10.29K
Net interest expenses
-1.39M
-1.72M
-1.44M
1.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
31.19M
44.35M
36.14M
53.25M
Gain or loss from assets sale
482.28K
-482.28K
-
1.07K
AI content may include mistakes. Learn more
Google apps